Table 1 Summary of study findings.

From: Characterization of motor and non-motor features associated with bilateral nigral degeneration due to A53T alpha-synuclein in female rats

Behavioral domain

Test

Measure

Statistical Significance

Effect of A53T a-Syn overexpression

Depression-like

Sucrose preference test

Sucrose preference

Interaction: F (1, 74) = 4.196, p = 0.0447

Time: F (1, 74) = 8.057, p = 0.0058

Group: F (1, 74) = 1.862, p = 0.1765

Week 3: Null

Week 6:\(\downarrow\)

Anxiety

Novelty suppressed feeding

Latency to feeding

Interaction: F (1, 74) = 2.448, p = 0.1220

Time: F (1, 74) = 1.776, p = 0.1868

Group: F (1, 74) = 0.1237, p = 0.7260

Week 3: Null

Week 6: Null

Open field

Time spent in the periphery

Interaction: F (1, 74) = 0.09539, p = 0.7584

Time: F (1, 74) = 8.478, p = 0.0049

Group: F (1, 74) = 0.5779, p = 0.4498

Week 3: Null

Week 6: Null

Recognition memory

Novel object recognition

Recognition index

Interaction: F (1, 74) = 0.3820, p = 0.5384

Time: F (1, 74) = 0.1927, p = 0.6620

Group: F (1, 74) = 0.04472, p = 0.8331

Week 3: Null

Week 6: Null

Olfaction

Habituation—dishabituation test

Cross-habituation index

Interaction: F (1, 74) = 0.2718, p = 0.6037

Time: F (1, 74) = 2.318, p = 0.1322

Group: F (1, 74) = 2.450, p = 0.1218

Week 3: Null

Week 6: Null

Locomotion

Open field

Total distance

Interaction: F (1, 74) = 0.2598, p = 0.6118

Time: F (1, 74) = 0.2326, p = 0.6310

Group: F (1, 74) = 7.956, p = 0.0061

Week 3: Null

Week 6:\(\downarrow\)

Mean speed

Interaction: F (1, 74) = 0.9059, p = 0.3443

Time: F (1, 74) = 0.9379, p = 0.3360

Group: F (1, 74) = 7.982, p = 0.0061

Week 3: Null

Week 6:\(\downarrow\)

Grid walking test

Slip ratio

Interaction: F (1, 74) = 1.178, p = 0.2812

Time: F (1, 74) = 0.004504, p = 0.9467

Group: F (1, 74) = 22.28, p < 0.0001

Week 3: \(\uparrow\)

Week 6:\(\uparrow\)

Grid walking test after L-DOPA administration

Slip ratio

Interaction: F (1, 18) = 0.6821, p = 0.4197

Injection: F (1, 18) = 4.919, p = 0.0397

Treatment: F (1, 18) = 0.3644, p = 0.5536

L-DOPA: \(\downarrow\)

Saline: Null

  1. The group factor refers to EV vs A53T, the time factor refers to week 3 versus week 6, the injection factor refers to baseline vs treatment with L-DOPA/saline, and the treatment factor refers to saline vs L-DOPA.